Atlanta Clinical and Translational Science Institute (ACTSI) Renewal

要实现CTSA愿景，对以下项目的质量和价值产生持续和变革性的影响 临床和翻译研究，来自三个学术机构的领导-埃默里大学、莫尔豪斯 医学院和佐治亚理工学院，以及其他合作组织成立 2007年，亚特兰大临床与转化科学研究所(ACTSI)。ACTSI已经整合了 发现、教育、培训和社区参与计划，并产生了前所未有的 我们社区的临床和转化性研究的转化水平。ACTSI已经开发出一种 通过支持673名研究人员、520个项目、93个项目，亚特兰大为临床和转化性研究提供“家” 96个研究领域的试点项目，超过193个联邦(PHS)拨款，134个现任或毕业的MSCR，KL或 TL学者，以及超过75名活跃的实习生。ACTSI的支持也为661项科学研究做出了贡献 出版，使机构间的合作增加了两倍，并在临床方面取得了重要的科学突破 和翻译科学。在使命的指引下，“通过伦理社区的参与，重点 教育和培训，以及对探索的创新支持，迅速成为亚太技转中心的合作伙伴 并有效地将科学发现转化为影响亚特兰大社区所有人口的技术 五年内，11个重点职能项目将负责实施三个扩展的具体目标。 目标1：通过跨学科合作促进发现，发展新的和新兴的 技术、药物、设备、诊断和生物学，并将这些发现有效地转化为 有益于人类健康。目标2：扩大和改进优秀项目，教育和培训成长型人才 培养种族多元化的干部、临床医生科学家，并增加能力和基础设施，以促进 多学科翻译研究团队。目标3：积极让社区参与研究，这将 使公众对科学发现和新知识的转化产生信任，最终 增强我们所服务社区的健康。

To address the CTSA vision to have a sustained and transformative influence on the quality and value of clinical & translational research, leadership from three academic institutions - Emory University, Morehouse School of Medicine, and Georgia Institute of Technology, along with other collaborative organizations formed in 2007, the Atlanta Clinical and Translational Science Institute (ACTSI). The ACTSI has integrated discovery, education, training and community engagement programs and engendered an unprecedented level of transformation in clinical and translational research in our community. The ACTSI has developed an Atlanta "home" for clinical and translational research through support of: 673 investigators, 520 projects, 93 pilot projects in 96 research areas, over 193 federal (PHS) grants, 134 current or graduated MSCR, KL, or TL scholars, and over 75 additional active trainees. ACTSI support has also contributed to 661 scientific publications, tripled inter-institutional collaborations, and led to important scientific breakthroughs in clinical and translational science. Guided by the mission, "[tjhrough ethical community engagement, focused education and training, and innovative support of discovery, the collaborative partners ofthe ACTSI rapidly and efficiently translate scientific discoveries to impact all populations ofthe Atlanta community," in the next five years, eleven key function programs will be charged with implementing three expanded specific aims. Aim 1: Promote discovery through inter-disciplinary collaboration, the development of novel and emerging technologies, drugs, devices, diagnostics and biologies, and the efficient translation of these discoveries to benefit human health. Aim 2: Expand and improve outstanding programs to educate and train a growing cadre of ethnically diverse, clinician scientists, and increase the capacity and infrastructure to foster multidisciplinary translational research teams. Aim 3: Actively engage the community in research that will engender the public trust in scientific discovery and the translation of new knowledge that ultimately enhances the health ofthe communities we serve.